Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00096954
Status:
COMPLETED
Last Update Posted:
2017-06-14
First Post:
2004-11-17
Brief Title:
A Prospective Randomized Double-Blind Study of the Efficacy of Omalizumab Xolair in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat EXACT
Sponsor:
Genentech Inc
Organization:
Genentech Inc